Bismuth Subcarbonate
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB11281 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 14 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | insomnia (disease) | KG + DL |
| 2 | enterocolitis (disease) | KG + DL |
| 3 | irritable bowel syndrome | KG + DL |
| 4 | neurocirculatory asthenia | KG + DL |
| 5 | acute intermittent porphyria | KG + DL |
| 6 | sleep disorder, initiating and maintaining sleep | KG + DL |
| 7 | adult-onset myasthenia gravis | KG + DL |
| 8 | myasthenia gravis with thymus hyperplasia | KG + DL |
| 9 | neonatal myasthenia gravis | KG + DL |
| 10 | autoimmune disease of peripheral nervous system | KG + DL |
| 11 | myasthenia, limb-girdle, autoimmune | KG + DL |
| 12 | disease of receptor activity | KG + DL |
| 13 | dysautonomia | KG + DL |
| 14 | autonomic nervous system disease | KG + DL |
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.